The role of Pim-1 kinases in inflammatory signaling pathways
Inflammation Research · 2024
DOI: 10.1007/s00011-024-01924-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation Research, 2024. Verfasst von Hye Suk Baek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Lipopolysaccharides, Signal Transduction, Inflammation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Objective and design This observational study investigated the regulatory mechanism of Pim-1 in inflammatory signaling pathways. Materials THP-1, RAW 264.7, BV2, and Jurkat human T cell lines were used. Treatment None.
Methods
Lipopolysaccharide (LPS) was used to induce inflammation, followed by PIM1 knockdown. Western blot, immunoprecipitation, immunofluorescence, and RT-PCR assays were used to assess the effect of PIM1 knockdown on LPS-induced inflammation.
Results
PIM1 knockdown in macrophage-like THP-1 cells suppressed LPS-induced upregulation of pro-inflammatory cytokines, inducible nitric oxide synthase, cyclooxygenase-2, phosphorylated Janus kinase, signal transducer and activator of transcription 3, extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38, and nuclear factor kappa B p65 (NF-κB p65). It also suppressed upregulation of inhibitor of NF-κB kinase α/β and enhanced the nuclear translocation of NF-κB p65. Moreover, it inhibited the upregulation of Nod-like receptor family pyrin domain-containing 3 (NLRP3) and cleavage of caspase-1 induced by co-treatment of LPS with adenosine triphosphate. Additionally, p-transforming growth factor-β-activated kinase 1 (TAK1) interacted with Pim-1. All three members of Pim kinases (Pim-1, Pim-2, and Pim-3) were required for LPS-mediated inflammation in macrophages; however, unlike Pim-1 and Pim-3, Pim-2 functioned as a negative regulator of T cell activity.
Conclusions
Pim-1 interacts with TAK1 in LPS-induced inflammatory responses and is involved in MAPK/NF-κB/NLRP3 signaling pathways. Additionally, considering the negative regulatory role of Pim-2 in T cells, further in-depth studies on their respective functions are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea.
- Department of Pharmacology, Chonnam University, Gwangju, 61469, Republic of Korea.
- Institute of Medical Science, Keimyung University, Daegu, 42601, Republic of Korea.
- Institute for Cancer Research, Keimyung University Dongsan Medical Center, Dalseo-gu, Daegu, 42601, Republic of Korea.
- Center for Forensic Pharmaceutical Science, Keimyung University, Daegu, 42601, Republic of Korea.
- Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea. god98005@dsmc.or.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Baek, H. S., Kim, N., Park, J. W., Kwon, T. K., & Kim, S. (2024). The role of Pim-1 kinases in inflammatory signaling pathways. Inflammation Research. https://doi.org/10.1007/s00011-024-01924-2
Vancouver
Baek HS, Kim N, Park JW, Kwon TK, Kim S. The role of Pim-1 kinases in inflammatory signaling pathways. Inflammation Research. 2024. doi:10.1007/s00011-024-01924-2
BibTeX
@article{Baek2024,
author = {Baek, Hye Suk and Kim, Nacksung and Park, Jong Wook and Kwon, Taeg Kyu and Kim, Shin},
title = {The role of Pim-1 kinases in inflammatory signaling pathways},
journal = {Inflammation Research},
year = {2024},
doi = {10.1007/s00011-024-01924-2}
}
EUVIMED